That equates to $16.25 per share, a 6% premium over the current market price. The deal will expand Tempus’ molecular residual disease test offerings, allowing the company to better support cancer patients.

In emergency settings, female physicians order more tests and admit more patients than their male peers. The difference is not pronounced, but its presence suggests women physicians may have a greater tendency to consider peripheral assessment factors. 

More than 750,000 devices are included in the new Class II recall. At this time, however, no devices need to be returned to the manufacturer. 

Of all the blunders for which a hospital can get sued, switching babies at birth has to rank among the least worried-about by lawyers and risk managers. That doesn’t mean it never happens. 

Back in June, CMS proposed significant updates to its current TAVR policies. Three leading healthcare societies have now joined forces to share their own perspective on the potential updates. 

Cardiologists and vascular surgeons were previously told they could still use the device if necessary. Now, however, the message is that they should return the product to the manufacturer.

The wrongful death lawsuit against Napoleon Maminta, MD, was filed in 2023, following an investigation from state and federal regulators into his prescribing practices. He has been formally accused of multiple violations that could threaten his license to practice medicine.

The incident happened in 2019 at a WakeMed hospital in Raleigh, North Carolina. Both the facility and the physician who performed the maneuver during the birth of Naqah Lake were found by a jury to be liable for the boy’s injuries. The verdict sets a record for the county.